Gulf Pharmaceutical Industries PSC 2025 IR
The report outlines Julphar's strategic, financial, and ESG performance for the fiscal year 2025. Key highlights include the launch of three locally manufactured insulin analogues and a strategic partnership with Dong-A ST to commercialize a Darbepoetin Alfa biosimilar in the MENA region. The company updated its materiality assessment, introducing seven new material topics and establishing its first formal sustainability framework. Environmentally, Julphar reduced its total energy consumption to 881,284,447 GJ and achieved a 60.1% water recycling rate through reverse osmosis. Financially, net sales from continuing operations increased by 8.4% to AED 1,075.5 million, while net debt decreased by 71.1%.
Company: Gulf Pharmaceutical Industries PSC
Sector: Manufacturing
Country: United Arab Emirates
Year: 2025
Type: IR
Pages: 143
Back to company
Gulf Pharmaceutical Industries PSC
Integrated Report
The report outlines Julphar's strategic, financial, and ESG performance for the fiscal year 2025. Key highlights include the launch of three locally manufactured insulin analogues and a strategic partnership with Dong-A ST to commercialize a Darbepoetin Alfa biosimilar in the MENA region. The company updated its materiality assessment, introducing seven new material topics and establishing its first formal sustainability framework. Environmentally, Julphar reduced its total energy consumption to 881,284,447 GJ and achieved a 60.1% water recycling rate through reverse osmosis. Financially, net sales from continuing operations increased by 8.4% to AED 1,075.5 million, while net debt decreased by 71.1%.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2025 - Dec 31, 2025
Fiscal Year
2025
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees